Latest filing published 15 May 2013 for China Biologic Products, Inc., €48.1M.
Insider track record
No signal scores available.
Lin Ling Li: trading record in brief
This profile gathers the share dealings of Lin Ling Li in China Biologic Products, Inc. In total, 3 filings cover trades dated from 31 August 2010 to 14 May 2013.
No open-market purchase appears, only 3 sales worth €70.7M. So far in 2013, the count stands at no purchases and 1 sale.
Most recently, on 15 May 2013, the filings show an open-market sale worth €48.1M in China Biologic Products, Inc. The median gap between a trade and its publication by SEC (Form 4) is 3 days. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Lin Ling Li
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,112,920 shares@ US$20.00Common Stock, par value $.0001 per shareSEC:0001062993-13-002518:0
- 1,500,000 shares@ US$13.00Common Stock, par value $.0001 per shareSEC:0001062993-10-004169:0
- 770,000 shares@ US$13.00Common Stock, par value $.0001 per shareSEC:0001062993-10-002916:0
3 of 3 declarations